Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

Liver disease, particularly viral hepatitis and hepatocellular carcinoma (HCC), is a global healthcare burden and leads to more than 2 million deaths per year worldwide. Despite some success in diagnosis and vaccine development, there are still unmet needs to improve diagnostics and therapeutics for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Huimin, Ju, Enguo, Yi, Ke, Xu, Weiguo, Lao, Yeh‐Hsing, Cheng, Du, Zhang, Qi, Tao, Yu, Li, Mingqiang, Ding, Jianxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693080/
https://www.ncbi.nlm.nih.gov/pubmed/34665528
http://dx.doi.org/10.1002/advs.202102051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693080/
https://www.ncbi.nlm.nih.gov/pubmed/34665528
http://dx.doi.org/10.1002/advs.202102051

Ejemplares similares